Perennial Ryegrass Allergy Shots: Thunderstorm Asthma Protection
Perennial ryegrass (Lolium perenne) caused the Melbourne 2016 thunderstorm asthma event — 10 deaths and ~10,000 ER presentations. FDA-standardized (g5, 100,000 BAU/mL), it is covered by Timothy SCIT via >90% Lol p 1/Phl p 1 cross-reactivity. Post-event data shows 71% of immunotherapy-treated patients were asymptomatic during the catastrophic storm.
About Curex’s SCIT program
Curex’s at-home allergy shots (SCIT) are coming soon and focus on the most common environmental allergens:
- • Pollens — tree, grass, weed & ragweed
- • Pet dander — cat & dog
- • Dust mites
- • Molds — Alternaria & mold mix
Perennial Ryegrassis covered here for general education and may not be part of Curex’s current treatment set. Join the waitlist and our care team will help confirm your options.
Perennial Ryegrass Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to perennial ryegrass — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of perennial ryegrass allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of perennial ryegrass immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of perennial ryegrass extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for perennial ryegrass allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
- Or at home with no clinic visits— Curex’s Virtual Shot Room model delivers the same SCIT program with live video supervision by trained Curex clinical staff for the first injection from each new vial or concentration and restarts after gaps or reactions.
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing perennial ryegrass extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription perennial ryegrass immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat perennial ryegrass allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Perennial Ryegrass?
The biology, taxonomy, and clinical fingerprint of Perennial Ryegrass — the foundation of how SCIT targets it.
Lolium perenne seed head. Oregon's Willamette Valley produces over two-thirds of the world's commercial grass seed, making perennial ryegrass the highest-volume grass pollen producer in North America.
- Scientific name
- Lolium perenne
- Family
- PoaceaeGrass family
- Type
- Cool-season perennial turfgrass, hay, and seed-crop pollen
- Native to
- Europe; dominant grass seed crop in Oregon's Willamette Valley
- Allergen proteins
- Lol p 1 (major) — Group 1 beta-expansin, ~90% sequence identity with Phl p 1 (van Ree et al. 1989)Lol p 5 (major) — Group 5 ribonuclease-like, >85% sensitization in rye-allergic patients (Pooideae-specific)Lol p 2, 3, 4 — Group 2/3/4 homologsProfilin (Lol p 12 homolog) — pan-allergen
- Particle size
- 26–35 μm
- Avoidance difficulty
- Nearly impossible
How Perennial Ryegrass Allergy Presents
Symptoms by body system — useful for distinguishing Perennial Ryegrass sensitivity from overlapping allergies and infections.
Respiratory
- Sudden severe bronchospasm during thunderstorms — the defining thunderstorm-asthma risk
- Profuse nasal discharge and sneezing during June Pacific Northwest peak counts
- Asthma exacerbation triggered by sub-pollen particles formed when ryegrass grains rupture in humidity
- Chest tightness and wheeze on days when counts exceed 200 grains/m³ in Eugene or Portland
- Persistent allergic rhinitis throughout the May–July season in seed-producing regions
Ocular
- Intense bilateral eye itching and redness during June peak counts
- Watery discharge and eyelid swelling on high-count outdoor days
- Photophobia during severe allergic conjunctivitis episodes
- Burning eye sensation aggravated by wind-driven pollen near seed fields
Dermal
- Hives from direct contact with ryegrass seed heads during sports or farm work
- Atopic dermatitis flares during June pollen peak
- Pruritus at pollen-exposed skin sites on high-count days
- Contact urticaria from handling ryegrass seed
Systemic
- Severe fatigue during the Eugene/Portland June peak — counts 5× the 'Very High' threshold
- Sleep disruption and anxiety during thunderstorm-asthma threat periods
- OAS (oral tingling) from profilin cross-reactivity with melon, tomato, peach, celery
- Quality of life severely impacted in Pacific Northwest residents during seed-harvest season
The Melbourne 2016 thunderstorm asthma follow-up is the single most underappreciated argument for committing to grass immunotherapy. Seventy-one percent of immunotherapy-treated grass-allergic patients were asymptomatic during a catastrophic event that killed 10 people and overwhelmed Melbourne's emergency system, versus only 24% of untreated grass-allergic patients. That's not a marginal benefit — that's protection when it matters most.
When & Where Perennial Ryegrass Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: June in Pacific Northwest (Eugene/Portland); April–June in southern overseed contexts· Approximately 10–12 weeks of significant exposure; extreme counts in Willamette Valley during June
US Exposure Map
5 high-intensity statesExposure intensity by state (text version)
- ME:
- Moderate
- VT:
- Moderate
- NH:
- Moderate
- WA:
- High
- MT:
- High
- ND:
- Low
- MN:
- Moderate
- WI:
- Moderate
- MI:
- Moderate
- NY:
- Moderate
- MA:
- Moderate
- OR:
- High
- ID:
- High
- WY:
- Moderate
- SD:
- Low
- IA:
- Moderate
- IL:
- Moderate
- IN:
- Moderate
- OH:
- Moderate
- PA:
- Moderate
- NJ:
- Moderate
- CT:
- Moderate
- RI:
- Moderate
- CA:
- High
- NV:
- Low
- UT:
- Low
- CO:
- Moderate
- NE:
- Low
- MO:
- Low
- KY:
- Low
- WV:
- Low
- VA:
- Low
- MD:
- Low
- DE:
- Low
- AZ:
- Low
- NM:
- Low
- KS:
- Low
- AR:
- Low
- TN:
- Low
- NC:
- Low
- SC:
- Low
- OK:
- Low
- LA:
- Low
- MS:
- Low
- AL:
- Low
- GA:
- Low
- TX:
- Low
- FL:
- Low
- AK:
- Low
- HI:
- Low
What Perennial Ryegrass Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Perennial ryegrass Lol p 1 shares ~90% sequence identity with Timothy's Phl p 1 (van Ree et al. 1989) — among the highest cross-reactivity values in the Pooideae, making a single Timothy SCIT vial fully cross-covering for ryegrass sensitization.
Lol p 1 shares ~90% sequence identity with Phl p 1 (van Ree et al. 1989); Grastek covers ryegrass
76% antigenic similarity — closest molecular sibling of perennial rye (Pham & Baldo 1995)
Lol p 12 profilin cross-reacts with food profilins; heat-labile, cooking eliminates risk
Grass Pollen–Food Profilin Syndrome
Ryegrass pollen profilin (Lol p 12 homolog) cross-reacts with profilins in raw tomato, melon, peach, celery, and other fresh produce, causing oral tingling or itching in affected patients. Symptoms are mild, localized, and resolve quickly. Cooking or processing food inactivates the profilin completely — cooked versions of these foods are safely tolerated.
Is SCIT Right for Your Perennial Ryegrass Allergy?
Answer 5 questions to evaluate your candidacy for perennial ryegrass allergy shots — especially important for Pacific Northwest patients and anyone who has experienced thunderstorm-triggered asthma.
How severe are your grass allergy symptoms during the May–July season?
The Perennial Ryegrass SCIT Protocol
Perennial ryegrass SCIT uses FDA-standardized Lolium perenne extract (g5, 100,000 BAU/mL) or, equivalently, Timothy or a 5-grass mix via Pooideae cross-reactivity. For Pacific Northwest patients with extreme June counts, reaching full maintenance dose before June is especially important.
Your allergist escalates from highly diluted Lolium perenne or Timothy extract to the maintenance concentration. For Pacific Northwest patients targeting the June peak, build-up should begin in January — 6 months before peak counts. The Practice Parameter notes that for patients with extreme seasonal exposure (such as Willamette Valley residents), reaching full maintenance dose before the season onset is clinically important. A 30-minute post-injection observation period is required at every visit.
Ongoing maintenance injections sustain immune tolerance. Importantly, continuing injections during grass season does NOT increase risk for most patients at maintenance dose — it is actually the period of greatest clinical protection. Your allergist will advise on the co-seasonal protocol appropriate for your exposure environment. All injections require 30-minute observation.
Calderon Cochrane 2007 demonstrated lasting benefit from grass SCIT after completing the full course. For ryegrass-allergic asthmatics, continued or indefinite treatment may be discussed given the thunderstorm asthma risk associated with cessation of immunological protection.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Perennial Ryegrass SCIT
The most compelling efficacy data for perennial ryegrass SCIT comes not from a controlled RCT but from a natural disaster: the Melbourne 2016 thunderstorm asthma event, where real-world protection of immunotherapy-treated patients was documented at 71% asymptomatic versus 24% for untreated grass-allergic individuals.
- Immunotherapy patients asymptomatic (Melbourne 2016)71%Australian post-event analyses (D'Amato 2016; Thien et al. 2018, Lancet Planet Health 2:e255) — 71% treated vs 24% untreated asymptomatic
- Symptom-medication score reduction (Pooideae SCIT class)32%Frew et al. 2006, JACI 117:319, N=410 — class-equivalent for perennial rye via Pooideae cross-reactivity
- Standardized mean difference (symptoms, 51 trials)73%Calderon et al. 2007, Cochrane Database — SMD -0.73; includes Lolium-containing grass extracts
No perennial ryegrass-specific SCIT RCT has been published; efficacy extrapolates from the Pooideae class evidence. However, the Melbourne 2016 natural experiment provides the most compelling real-world evidence in the grass SCIT literature — 71% asymptomatic protection against a catastrophic thunderstorm asthma event in immunotherapy-treated patients.
Ready to skip the surprise bills?
At-home allergy shots (SCIT) are designed by board-certified allergists. See the listed SCIT plan rate in our pricing record and request a quote for eligibility, initiation and total care costs.
- MD-ledBoard-certified allergists
- QuoteTotal care estimate
- 50K+Patients treated
- HSA/FSAEligible
Perennial Ryegrass SCIT Side Effects
Perennial ryegrass SCIT has the same local and systemic reaction profile as other FDA-standardized Pooideae extracts. Grass-allergic asthmatics need careful pre-injection asthma assessment due to elevated baseline risk.
Local reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Injection site swelling Expected; resolves within 2–4 hours | Rate 30–50% | Mild |
Injection site itching Cold compress provides relief; report sizes >5 cm to allergist | Rate 25–50% | Mild |
Large local reaction (>5 cm) Prompts dose adjustment; document precisely | Rate 5–10% | Moderate |
Delayed local swelling 4–8 hours post-injection; common during early build-up | Rate 5–15% | Mild |
Systemic reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Generalized urticaria Immediate epinephrine and antihistamine; dose reduction at next visit | Rate 0.1–0.5% per injection | Moderate |
Rhinitis or conjunctivitis flare Self-resolving; antihistamine as needed | Rate 0.5–2% | Mild |
Asthma exacerbation CRITICAL for ryegrass-allergic asthmatics: assess peak flow (>70% predicted) before every injection; withhold if uncontrolled | Rate 0.1–0.3% | Moderate |
Anaphylaxis 30-minute observation and a prescribed epinephrine auto-injector confirmed on hand at the injection location are the primary safety requirements | Rate <0.001% per injection | Severe |
For grass-allergic asthmatics — especially those with a thunderstorm-asthma history — the pre-injection asthma assessment is the most critical safety step. All SCIT injections require a mandatory 30-minute post-injection observation period and a prescribed epinephrine auto-injector confirmed on hand at the injection location.
SCIT vs Alternatives for Perennial Ryegrass
Perennial ryegrass-allergic patients — particularly those with asthma or thunderstorm-asthma risk — have the strongest clinical argument of any grass-allergic population for choosing long-term immunotherapy over medications alone.
| Criterion | SCITBest | SLIT (Oralair includes rye) | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | High — 71% protected in Melbourne 2016 event | Moderate–High (10–34% TCS reduction) | Very low (counts >1,000 grains/m³ in Oregon impossible to avoid) | Moderate (symptomatic only; no thunderstorm asthma protection) |
| 5-yr cost estimate | $3,500–$15,000 | $3,000–$8,000 | Minimal | $500–$2,000/yr |
| Duration of benefit | 7–12 years | 2–3 years post-treatment | Only during avoidance | Only while taking |
| Convenience | At-home weekly shot with Curex covering perennial rye; first dose Virtual Shot Room–supervised | Daily at-home tablet | Impossible in PNW during June | Daily |
| Safety | Excellent with asthma monitoring | Very safe; first dose in clinic | Safe | Good; rescue inhaler critical |
| Lasting effect after stopping | Yes — durable remission | Partial | No | No |
SCITBest
SLIT (Oralair includes rye)
Avoidance
Medications
SCIT is particularly compelling for ryegrass-allergic asthmatics, given the Melbourne 2016 thunderstorm asthma protection data. For patients who want that protection without weekly clinic visits, Curex delivers the at-home allergy shot with pricing confirmed in a current program quote: a personalized immunotherapy serum sterile-compounded to USP <797> covering perennial rye and all cross-reactive Pooideae grasses, with a prescribed epinephrine auto-injector confirmed on hand, the first injection from each new vial or concentration supervised live in the Virtual Shot Room, gradual week-by-week escalation, and board-certified allergist oversight — one weekly shot you give yourself at home.
What Perennial Ryegrass SCIT Actually Costs
Perennial ryegrass (Lolium perenne, g5) is FDA-standardized, supporting medical necessity for insurance reimbursement. Asthma comorbidity strengthens the prior authorization case. Most commercial plans cover SCIT under allergy benefits; Pacific Northwest-specific allergy coverage should be verified given the extreme local exposure environment. Curex at-home IgE testing identifies specific perennial ryegrass sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
See the listed Environmental Allergy Shots Plan rate, commercial terms dated 2026-10-12; consultations are included without copay. Confirm availability, eligibility, other included services, testing, any in-person care, insurance responsibility and billing cadence in your written quote before enrolling.
Join the waitlistStop guessing about your perennial ryegrass allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Perennial Ryegrass SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Thunderstorm asthma occurs when grass pollen grains — particularly Lolium perenne — absorb moisture from raindrops and atmospherically increasing humidity before and during a thunderstorm. This osmotic stress causes the pollen grains to rupture, releasing thousands of sub-pollen particles 0.5–2.5 micrometers in diameter per grain. Unlike whole pollen (26–35 μm), sub-pollen particles bypass upper airway defenses and penetrate directly into bronchi and bronchioles, triggering acute bronchospasm even in patients without prior asthma. The Melbourne 2016 event — 10 deaths and approximately 10,000 emergency presentations over one night — is the most documented example. Downdraft winds in the storm concentrated atmospheric pollen, and the simultaneous rupture event flooded Melbourne's atmosphere with sub-pollen particles at unprecedented density.
Ryegrass sensitization typically persists regardless of relocation — the immune memory cannot be undone simply by reducing exposure. However, moving to a region with lower ryegrass counts will reduce symptom severity during peak season, as symptom intensity correlates with exposure dose. Patients who relocate from the Willamette Valley to low-ryegrass regions often report significant improvement, but sensitization remains measurable by skin test and serum IgE. Immunotherapy initiated before relocation or continued after moving is the only approach that modifies the underlying sensitization rather than just reducing symptoms through avoidance.
Yes — Italian ryegrass (Lolium multiflorum) is a closely related species with very high cross-reactivity to perennial ryegrass (L. perenne) via shared Pooideae Group 1 and Group 5 allergens. L. multiflorum is widely used for winter overseeding of warm-season lawns in the South, so patients in southeastern states may experience grass symptoms in April through June from Italian ryegrass while their Bermuda grass lawn is still dormant. A standard Pooideae SCIT vial (Timothy or Lolium perenne g5) covers Italian ryegrass via cross-reactivity. The same is true for Oralair, which lists Lolium perenne as a direct component.
For Pacific Northwest patients targeting the June peak in Eugene, Portland, or similar cities, your allergist should initiate SCIT build-up in January — allowing approximately 6 months to reach maintenance. Standard guidelines recommend beginning build-up at least 12 weeks before the peak season, but given the extreme June counts in the Willamette Valley (regularly exceeding 1,000 grains/m³), reaching full maintenance dose before the season onset is especially important. Trying to initiate SCIT during active season, or during peak pollen days, significantly increases the risk of systemic reactions.
Yes — post-Melbourne 2016 analyses are the most compelling evidence for this. Australian researchers found that 71% of grass-immunotherapy-treated patients were completely asymptomatic during the catastrophic November 5, 2016 thunderstorm asthma event, compared to only 24% of untreated grass-allergic patients. The underlying mechanism is that SCIT reduces IgE-mediated mast cell reactivity in the lower airway — so when sub-pollen particles reach the bronchi during a thunderstorm rupture event, the immune response is blunted rather than explosive. This protective effect is one of the strongest arguments for committing to a 3–5 year SCIT course for grass-allergic asthmatics in high-ryegrass regions.
Yes — grass pollen SCIT is appropriate for children typically from age 5 and older per AAAAI guidelines. For children with asthma, early SCIT is particularly important given the thunderstorm asthma risk associated with grass sensitization. Oralair (ages 10–65) is an FDA-approved SLIT tablet that directly includes perennial ryegrass as one of five components; Grastek (ages 5–65) covers ryegrass via Timothy Pooideae cross-reactivity. Note: Curex's at-home pilot is currently open to patients age 12 and older; pediatric patients require a trained adult caregiver physically present for every injection. A board-certified pediatric allergist should assess asthma control before initiating SCIT in children, as poorly controlled asthma increases the risk of systemic reactions.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Questions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.